دورية أكاديمية
أعرض في EDS

Intelligent Chinese Medicine: A New Direction Approach for Integrative Medicine in Diagnosis and Treatment of Cardiovascular Diseases.

التفاصيل البيبلوغرافية
العنوان: Intelligent Chinese Medicine: A New Direction Approach for Integrative Medicine in Diagnosis and Treatment of Cardiovascular Diseases.
المؤلفون: Wang ZY; The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China., Guo ZH; School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China. guozhihua112@163.com.; Hunan Key Laboratory of Colleges and Universities of Intelligent Traditional Chinese Medicine Diagnosis and Preventive Treatment of Chronic Diseases of Hunan Universities of Chinese Medicine, Changsha, 410208, China. guozhihua112@163.com.
المصدر: Chinese journal of integrative medicine [Chin J Integr Med] 2023 Jul; Vol. 29 (7), pp. 634-643. Date of Electronic Publication: 2023 May 24.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Chinese Journal of Integrated Traditional and Western Medicine Press Country of Publication: China NLM ID: 101181180 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1672-0415 (Print) Linking ISSN: 16720415 NLM ISO Abbreviation: Chin J Integr Med Subsets: MEDLINE
أسماء مطبوعة: Publication: 2007- : Berlin : Chinese Journal of Integrated Traditional and Western Medicine Press : Springer
Original Publication: Beijing, China : Watertown, MA : Chinese Association of the Integration of Traditional and Western Medicine : China Academy of Traditional Chinese Medicine ; Distributed by Relaxing Natural Health, [2003]-
مواضيع طبية MeSH: Cardiovascular Diseases*/therapy , Cardiovascular Diseases*/drug therapy , Integrative Medicine*, Humans ; Aged ; Medicine, Chinese Traditional ; Artificial Intelligence
مستخلص: High mortality rates from cardiovascular diseases (CVDs) persist worldwide. Older people are at a higher risk of developing these diseases. Given the current high treatment cost for CVDs, there is a need to prevent CVDs and or develop treatment alternatives. Western and Chinese medicines have been used to treat CVDs. However, several factors, such as inaccurate diagnoses, non-standard prescriptions, and poor adherence behavior, lower the benefits of the treatments by Chinese medicine (CM). Artificial intelligence (AI) is increasingly used in clinical diagnosis and treatment, especially in assessing efficacy of CM in clinical decision support systems, health management, new drug research and development, and drug efficacy evaluation. In this study, we explored the role of AI in CM in the diagnosis and treatment of CVDs, and discussed application of AI in assessing the effect of CM on CVDs.
(© 2023. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.)
References: Jin L, Shi X, Yang J, et al. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell 2021;12:346–359. (PMID: 3298968610.1007/s13238-020-00785-9)
Budreviciute A, Damiati S, Sabir DK, et al. Management and prevention strategies for non-communicable diseases (NCDs) and their risk factors. Front Public Health 2020;26:574111. (PMID: 10.3389/fpubh.2020.574111)
Hao P, Jiang F, Cheng J, et al. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol 2017;69:2952–2966. (PMID: 2861919710.1016/j.jacc.2017.04.041)
Jiang Y, Zhao Q, Li L, et al. Effect of traditional Chinese medicine on the cardiovascular diseases. Front Pharmacol 2022;13:806300. (PMID: 35387325897863010.3389/fphar.2022.806300)
Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism 2017;69:S36–S40. (PMID: 10.1016/j.metabol.2017.01.011)
Guo Y, Ren X, Chen YX, et al. Artificial intelligence meets Chinese medicine. Chin J Integr Med 2019;25:648–653. (PMID: 3165048510.1007/s11655-019-3169-5)
Ren XG, Ren XY, Li X, et al. Research progress of artificial intelligence application in medicine. World Sci Tech Mod Tradit Chin Med Mater Med (Chin) 2022;24:762–770.
He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine. Nat Med 2019;25:30–36. (PMID: 30617336699527610.1038/s41591-018-0307-0)
Jiang F, Jiang Y, Zhi H, et al. Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol 2017;2:230–243. (PMID: 29507784582994510.1136/svn-2017-000101)
Ma L, Yang T. Construction and evaluation of intelligent medical diagnosis model based on integrated deep neural network. Comput Intell Neurosci 2021;2021:7171816. (PMID: 34868296863927610.1155/2021/7171816)
Wang X, Chen H, Ran AR, et al. Towards multi-center glaucoma OCT image screening with semi-supervised joint structure and function multi-task learning. Med Image Anal 2020;63:101695. (PMID: 3244286610.1016/j.media.2020.101695)
Chen X, Wang X, Zhang K, et al. Recent advances and clinical applications of deep learning in medical image analysis. Med Image Anal 2022;79:102444. (PMID: 3547284410.1016/j.media.2022.102444)
Wu S, Chen X, Pan J, et al. An artificial intelligence system for the detection of bladder cancer via cystoscopy: a multicenter diagnostic Study. J Natl Cancer Inst 2022;114:220–227. (PMID: 3447331010.1093/jnci/djab179)
Gros C, De Leener B, Dupont SM, et al. Automatic spinal cord localization, robust to MRI contrasts using global curve optimization. Med Image Anal 2018;44:215–227. (PMID: 2928898310.1016/j.media.2017.12.001)
Saldanha OL, Quirke P, West NP, et al. Swarm learning for decentralized artificial intelligence in cancer histopathology. Nat Med 2022;28:1232–1239. (PMID: 35469069920577410.1038/s41591-022-01768-5)
Zou Y, Zhao L, Zhang J, et al. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease. Ren Fail 2022;44:562–570. (PMID: 35373711898622010.1080/0886022X.2022.2056053)
You Y, Lai X, Pan Y, et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther 2022;7:156. (PMID: 35538061909074610.1038/s41392-022-00994-0)
Selvaraj G, Kaliamurthi S, Kaushik AC, et al. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms. J Biomed Inform 2018;86:120–134. (PMID: 3019565910.1016/j.jbi.2018.09.004)
Hosny A, Parmar C, Quackenbush J, et al. Artificial intelligence in radiology. Nat Rev Cancer 2018;18:500–510. (PMID: 29777175626817410.1038/s41568-018-0016-5)
Bhinder B, Gilvary C, Madhukar NS, et al. Artificial intelligence in cancer research and precision medicine. Cancer Discov 2021;11:900–915. (PMID: 33811123803438510.1158/2159-8290.CD-21-0090)
Nam D, Chapiro J, Paradis V, et al. Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction. JHEP Rep 2022;4:100443. (PMID: 35243281886711210.1016/j.jhepr.2022.100443)
Karatzia L, Aung N, Aksentijevic D. Artificial intelligence in cardiology: hope for the future and power for the present. Front Cardiovasc Med 2022;9:945726. (PMID: 36312266960863110.3389/fcvm.2022.945726)
Pham KT, Nabizadeh A, Selek S. Artificial intelligence and chatbots in psychiatry. Psychiatr Q 2022;93:249–253. (PMID: 35212940887334810.1007/s11126-022-09973-8)
Shmatko A, Ghaffari Laleh N, Gerstung M, et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology. Nat Cancer 2022;3:1026–1038. (PMID: 3613813510.1038/s43018-022-00436-4)
Mann M, Kumar C, Zeng WF, et al. Artificial intelligence for proteomics and biomarker discovery. Cell Syst 2021;12:759–770. (PMID: 3441154310.1016/j.cels.2021.06.006)
Vatansever S, Schlessinger A, Wacker D, et al. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: state-of-the-arts and future directions. Med Res Rev 2021;41:1427–1473. (PMID: 3329567610.1002/med.21764)
Yang X, Wang Y, Byrne R, et al. Concepts of artificial intelligence for computer-assisted drug discovery. Chem Rev 2019;119:10520–10594. (PMID: 3129497210.1021/acs.chemrev.8b00728)
Hao P, Jiang F, Cheng J, et al. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol 2017;69:2952–2966. (PMID: 2861919710.1016/j.jacc.2017.04.041)
Wei Z, Chen J, Zuo F, et al. Traditional Chinese medicine has great potential as candidate drugs for lung cancer: a review. J Ethnopharmacol 2023;300:115748. (PMID: 3616254510.1016/j.jep.2022.115748)
Zhou X, Shao T, Xie X, et al. Tongqiao Huoxue Decoction for the treatment of acute ischemic stroke: a systematic review and meta-analysis. J Ethnopharmacol 2022;283:114693. (PMID: 3460007410.1016/j.jep.2021.114693)
Zhao Z, Li Y, Zhou L et al. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine 2021;85:153308. (PMID: 3284323410.1016/j.phymed.2020.153308)
Liu M, Gao Y, Yuan Y, et al. Efficacy and safety of integrated traditional Chinese and Western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol Res 2020;158:104896. (PMID: 32438037721175910.1016/j.phrs.2020.104896)
Wang Y, Shi X, Li L, et al. The impact of artificial intelligence on traditional Chinese medicine. Am J Chin Med 2021;49:1297–1314. (PMID: 3424756410.1142/S0192415X21500622)
Wu J, Hu R, Li M, et al. Diagnosis of sleep disorders in traditional Chinese medicine based on adaptive neuro-fuzzy inference system. Biomed Signal Process Control 2021;70:102942. (PMID: 10.1016/j.bspc.2021.102942)
Yuan L, Yang L, Zhang S, et al. Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study. E Clin Med 2023;57:101834.
Xia SJ, Gao BZ, Wang SH, et al. Modeling of diagnosis for metabolic syndrome by integrating symptoms into physiochemical indexes. Biomed Pharmacother 2021;137:111367. (PMID: 3358826510.1016/j.biopha.2021.111367)
Wang X, Wang ZY, Zheng JH, et al. CM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med 2021;19:1–11. (PMID: 33516447)
Sun JH, Sun F, Yan B, et al. Data mining and systematic pharmacology to reveal the mechanisms of traditional Chinese medicine in mycoplasma pneumoniae pneumonia treatment. Biomed Pharmacother 2020;125:109900. (PMID: 3202823710.1016/j.biopha.2020.109900)
Sun J, Liu B, Yuan Y, et al. Disease markers and therapeutic targets for rheumatoid arthritis identified by integrating bioinformatics analysis with virtual screening of traditional Chinese medicine. Front Biosci (Landmark Ed) 2022;27:267. (PMID: 3622401010.31083/j.fbl2709267)
Miao H, Zhang Y, Yu X, et al. Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy. Front Pharmacol 2022;13:969930. (PMID: 36176440951342910.3389/fphar.2022.969930)
Xu H, Zhang Y, Wang P, et al. A comprehensive review of integrative pharmacology-based investigation: a paradigm shift in traditional Chinese medicine. Acta Pharm Sin B 2021;11:1379–1399. (PMID: 34221858824585710.1016/j.apsb.2021.03.024)
Wang S, Hou Y, Li X, et al. Practical implementation of artificial intelligence-based deep learning and cloud computing on the application of traditional medicine and Western medicine in the diagnosis and treatment of rheumatoid arthritis. Front Pharmacol 2021;12:765435. (PMID: 35002704873365610.3389/fphar.2021.765435)
Huang K, Zhang P, Zhang Z, et al. Traditional Chinese medicine (CM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther 2021;225:107843. (PMID: 33811957801133410.1016/j.pharmthera.2021.107843)
Pan HT, Xi ZQ, Wei XQ, et al. A network pharmacology approach to predict potential targets and mechanisms of “Ramulus Cinnamomi (cassiae)-Paeonia lactiflora” herb pair in the treatment of chronic pain with comorbid anxiety and depression. Ann Med 2022;1:413–425. (PMID: 10.1080/07853890.2022.2031268)
Yuan CC, Wang J, Shu B, et al. The concept of traditional Chinese medicine phenomics and the construction of related research system. J Tradit Chin Med (Chin) 2022;63:407–411.
Li S, Zhang P, Wang X, et al. Network target theory, key techniques and applications in traditional Chinese medicine. World Sci Tech Mod Tradit Chin Med Mater Med (Chin) 2022;24:3261–3269.
Lin Y, Wang XQ, Zhao H, et al. Discussion on methodology of evaluating the dominant diseases of traditional Chinese medicine. J Tradit Chin Med (Chin) 2021;62:1663–1667.
Chen J, Tao RQ, Song L, et al. Sydrome differentiation and treatment based on Chinese medicine advantages of disease. Lishizhen Med Mater Med Res (Chin) 2017;28:2552–2556.
Qiao LS, Li J, Xie L, et al. The exploration of a new approach for developing innovative Chinese herbal formulae by combining targeted transcriptome, expert experience and artificial intelligence: taking the development of antichronic heart failure innovative formula as an example. J Tradit Chin Med (Chin) 2023;64:217–224.
Zhang J, Zhu H, Chen Y, et al. Ensemble machine learning approach for screening of coronary heart disease based on echocardiography and risk factors. BMC Med Inform Decis Mak 2021;21:187. (PMID: 34116660819650210.1186/s12911-021-01535-5)
Cui J, Song L. Wrist pulse diagnosis of stable coronary heart disease based on acoustics waveforms. Comput Methods Programs Biomed 2022;214:106550. (PMID: 3486161710.1016/j.cmpb.2021.106550)
Zhou J, Li S, Wang X, et al. Weakly supervised deep learning for tooth-marked tongue recognition. Front Physiol 2022;13:847267. (PMID: 35492602903905010.3389/fphys.2022.847267)
Zhao W, Lu W, Li Z, et al. CM herbal prescription recommendation model based on multi-graph convolutional network. J Ethnopharmacol 2022;297:115109. (PMID: 3522778010.1016/j.jep.2022.115109)
Zhang H, Zhang J, Ni W, et al. Transformer- and generative adversarial network-based inpatient traditional Chinese medicine prescription recommendation: development study. JMIR Med Inform 2022;10:e35239. (PMID: 35639469919882610.2196/35239)
Wang J, Wang S, Zhu MX, et al. Risk prediction of major adverse cardiovascular events occurrence within 6 months after coronary revascularization: machine learning study. JMIR Med Inform 2022;10:e33395. (PMID: 35442202906928610.2196/33395)
Zuo HL, Linghu KG, Wang YL, et al. Interactions of antithrombotic herbal medicines with Western cardiovascular drugs. Pharmacol Res 2020;159:104963. (PMID: 3249771910.1016/j.phrs.2020.104963)
Li L, Wang Z, Wang J, et al. Enlightenment about using Chinese medicine constitutions for individualized medicine and construction of Chinese-style precision medicine: research progress with Chinese medicine constitutions. Sci China Life Sci 2021;64:2092–2099. (PMID: 3340006010.1007/s11427-020-1872-7)
Lai T, Guan Y, Men S, et al. ResNet for recognition of qideficiency constitution and balanced constitution based on voice. Front Psychol 2022;13:1043955. (PMID: 36544461976215310.3389/fpsyg.2022.1043955)
Wang J, Wu L. A comparison of health communication effectiveness and the improvement of management strategies: taking two Chinese traditional medicine hospitals’ WeChat public accounts as examples. BMC Health Serv Res 2020;20:1055. (PMID: 33213422767709610.1186/s12913-020-05901-3)
Yang J, Tian S, Zhao J, et al. Exploring the mechanism of CM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning. Pharmacol Res 2020;159:105034. (PMID: 3256531210.1016/j.phrs.2020.105034)
Gao T, Wang R, Zhang H, et al. Network pharmacology combined with metabolomics reveals the mechanism of Fuzi Decoction against chronic heart failure in rats. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1210:123435. (PMID: 3606370010.1016/j.jchromb.2022.123435)
Zhou W, Yang K, Zeng J, et al. FordNet: recommending traditional Chinese medicine formula via deep neural network integrating phenotype and molecule. Pharmacol Res 2021;173:105752. (PMID: 3448107210.1016/j.phrs.2021.105752)
Guo HX, Wang JR, Peng GC, et al. A data mining-based study on medication rules of Chinese herbs to treat heart failure with preserved ejection fraction. Chin J Integr Med 2022;28:847–854. (PMID: 3582995410.1007/s11655-022-2892-5)
فهرسة مساهمة: Keywords: Chinese medicine; Western medicine; artificial intelligence; cardiovascular diseases; heart failure; ischemic heart disease
تواريخ الأحداث: Date Created: 20230524 Date Completed: 20230703 Latest Revision: 20230703
رمز التحديث: 20230703
مُعرف محوري في PubMed: PMC10208185
DOI: 10.1007/s11655-023-3639-7
PMID: 37222830
قاعدة البيانات: MEDLINE
الوصف
تدمد:1672-0415
DOI:10.1007/s11655-023-3639-7